U.S. Markets closed
  • S&P 500

    4,088.85
    +80.84 (+2.02%)
     
  • Dow 30

    32,654.59
    +431.17 (+1.34%)
     
  • Nasdaq

    11,984.52
    +321.73 (+2.76%)
     
  • Russell 2000

    1,840.30
    +56.87 (+3.19%)
     
  • Crude Oil

    113.81
    +1.41 (+1.25%)
     
  • Gold

    1,812.80
    -6.10 (-0.34%)
     
  • Silver

    21.64
    -0.11 (-0.51%)
     
  • EUR/USD

    1.0553
    +0.0115 (+1.0975%)
     
  • 10-Yr Bond

    2.9680
    +0.0910 (+3.16%)
     
  • Vix

    26.10
    -1.37 (-4.99%)
     
  • GBP/USD

    1.2493
    +0.0169 (+1.3692%)
     
  • USD/JPY

    129.3840
    +0.3310 (+0.2565%)
     
  • BTC-USD

    30,447.55
    +295.58 (+0.98%)
     
  • CMC Crypto 200

    677.94
    +435.26 (+179.36%)
     
  • FTSE 100

    7,518.35
    +53.5503 (+0.72%)
     
  • Nikkei 225

    26,659.75
    +112.70 (+0.42%)
     

Zymergen to Report Third Quarter 2021 Financial Results on November 3, 2021

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

EMERYVILLE, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. (Nasdaq: ZY) today announced it will report financial results for the third quarter 2021 after market close on Wednesday, November 3rd, 2021. The company’s management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook.

A webcast of the conference call can be accessed at https://investors.zymergen.com/.

About Zymergen

Zymergen is a biofacturing company using biology to reimagine the world. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of industries. A unique combination of biology, chemistry, software and automation enables the company to design and create new materials.

Investor Contact
Carrie Mendivil/Mary Kate McDonough
investors@zymergen.com

Media Contact
Mike Dulin
mdulin@zymergen.com
502-777-2029